These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 3763616)
21. Research on antibacterial and antifungal agents. III. Synthesis of 1-ethyl-1,4-dihydro-4-oxo-7-(1-pyrryl)quinoline-3-carboxylic acid and of some 6-derivatives. Artico M; Corelli F; Massa S; Stefancich G; Panico S; Simonetti N Farmaco Sci; 1984 Nov; 39(11):910-24. PubMed ID: 6440810 [TBL] [Abstract][Full Text] [Related]
22. Transfer of ciprofloxacin to bile and determination of biliary metabolites in humans. Tanimura H; Tominaga S; Rai F; Matsumoto H Arzneimittelforschung; 1986 Sep; 36(9):1417-20. PubMed ID: 3790196 [TBL] [Abstract][Full Text] [Related]
23. Isolation and structure elucidation of an intermediate in the photodegradation of ciprofloxacin. Torniainen K; Askolin CP; Mattinen J J Pharm Biomed Anal; 1997 Nov; 16(3):439-45. PubMed ID: 9589402 [TBL] [Abstract][Full Text] [Related]
24. Structural identification and characterization of impurities in moxifloxacin. Kumar YR; Prasad Raju VV; Kumar RR; Eswaraiah S; Mukkanti K; Suryanarayana MV; Reddy MS J Pharm Biomed Anal; 2004 Mar; 34(5):1125-9. PubMed ID: 15019047 [TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of enrofloxacin in Korean catfish (Silurus asotus). Kim MS; Lim JH; Park BK; Hwang YH; Yun HI J Vet Pharmacol Ther; 2006 Oct; 29(5):397-402. PubMed ID: 16958784 [TBL] [Abstract][Full Text] [Related]
26. Synthesis of fluorine-18-labeled ciprofloxacin for PET studies in humans. Langer O; Mitterhauser M; Brunner M; Zeitlinger M; Wadsak W; Mayer BX; Kletter K; Müller M Nucl Med Biol; 2003 Apr; 30(3):285-91. PubMed ID: 12745020 [TBL] [Abstract][Full Text] [Related]
27. [A new synthetic antibacterial : 1-ethyl-6-fluoro-7-(4-methyl-1-piperazinyl)-4-oxo-1, 4-dihydroquinolin-3-carboxylic acid (1589 R.B.)]. Goueffon Y; Montay G; Roquet F; Pesson M C R Seances Acad Sci III; 1981 Jan; 292(1):37-40. PubMed ID: 6786770 [TBL] [Abstract][Full Text] [Related]
28. Absorption spectra of the 4f electron transitions of the praseodymium complex with 1-cyclopropyl-6-fluoro-1,4-dihydro-7-(4-ethyl-1-piperazinyl) -4-oxo-3-quinoline carboxylic acid hydrochloride and its analytical application. Wang N; Jiang W; Si Z; Liu F; Men Q; Xu X Anal Sci; 2001 Sep; 17(9):1091-4. PubMed ID: 11708065 [TBL] [Abstract][Full Text] [Related]
29. Effect of selected metal ions on the photodegradation of ciprofloxacin in the solid phase. Hubicka U; Krzek J J AOAC Int; 2008; 91(6):1331-8. PubMed ID: 19202793 [TBL] [Abstract][Full Text] [Related]
30. [Synthesis and antibacterial activities of 1-amino-6-fluoro-1,4-dihydro-4-oxo-7-(substituted) piperazinyl-3-quinolinecarboxylic acids and their derivatives]. Xin T; Ding J; Zhang XP Yao Xue Xue Bao; 1993; 28(11):865-9. PubMed ID: 8010004 [TBL] [Abstract][Full Text] [Related]
31. Structure elucidation of a photodegradation product of ciprofloxacin. Torniainen K; Mattinen J; Askolin CP; Tammilehto S J Pharm Biomed Anal; 1997 Apr; 15(7):887-94. PubMed ID: 9160254 [TBL] [Abstract][Full Text] [Related]
32. Distribution of [14C]-ciprofloxacin in experimentally induced intramuscular abscesses of rats. Steinke W; Haller I; Ruehl-Fehlert C Arzneimittelforschung; 1986 Nov; 36(11):1663-6. PubMed ID: 3814223 [TBL] [Abstract][Full Text] [Related]
33. Principles of clinical pharmacokinetics of antimicrobial drugs. Sams RA J Am Vet Med Assoc; 1984 Nov; 185(10):1068-71. PubMed ID: 6511566 [No Abstract] [Full Text] [Related]
34. Synthesis, in vitro and in vivo antimycobacterial activities of diclofenac acid hydrazones and amides. Sriram D; Yogeeswari P; Devakaram RV Bioorg Med Chem; 2006 May; 14(9):3113-8. PubMed ID: 16412646 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and in-vitro antimycobacterial evaluation of 1-(cyclopropyl/2,4-difluorophenyl/tert-butyl)-1,4-dihydro- 8-methyl-6-nitro-4-oxo-7-(substituted secondary amino)quinoline-3-carboxylic acids. Senthilkumar P; Dinakaran M; Chandraseakaran Y; Yogeeswari P; Sriram D Arch Pharm (Weinheim); 2009 Feb; 342(2):100-12. PubMed ID: 19137533 [TBL] [Abstract][Full Text] [Related]
36. Ciprofloxacin and oxociprofloxacin pharmacokinetics in patients on haemodialysis. Drinovec J; Mrhar A; Bren A; Primozic S; Karba R; Varl J; Kozjek F J Chemother; 1989 Jul; 1(4 Suppl):565-6. PubMed ID: 16312534 [No Abstract] [Full Text] [Related]
37. Regioselective transformation of ciprofloxacin to N-acetylciprofloxacin by the fungus Mucor ramannianus. Parshikov IA; Freeman JP; Lay JO; Beger RD; Williams AJ; Sutherland JB FEMS Microbiol Lett; 1999 Aug; 177(1):131-5. PubMed ID: 10436931 [TBL] [Abstract][Full Text] [Related]
38. [Synthesis and antibacterial activity of 7-substituted-1-ethyl(2-fluoro-ethyl)-6,8-difluoro-1,4-dihydro-4- oxoquinoline-3-carboxylic acid]. Yan L; Xu B; Ma Z; Zhu Y; Yang Q Yao Xue Xue Bao; 1998 May; 33(5):392-5. PubMed ID: 12017009 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration. Okuyama Y; Momota K; Morino A Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546 [TBL] [Abstract][Full Text] [Related]